News

Echothiophate (ECHO) Therapy Causes a Stir in the Low Vision Community

by Dan Roberts November 2003 (Updated January 29, 2009) A Connecticut ophthalmologist has been reporting success from a deceptively simple treatment on patients with Stargardt’s disease and other non-neovascular forms of retinal disease. Dr. Gerard Michael Nolan has performed the treatment, called ECHO therapy, for nearly three years on more than 200 patients at the [Read More]

Brain Reorganizes to Adjust for Loss of Vision

Atlanta (November 20, 2008) – A new study from Georgia Tech shows that when patients with macular degeneration focus on using another part of their retina to compensate for their loss of central vision, their brain seems to compensate by reorganizing its neural connections. Age related macular degeneration is the leading cause of vision loss [Read More]

Interleukin-6 and Interleukin-8 Linked to Dry AMD

by Dan Roberts (Updated November 10, 2008) Concentration of two cytokines, interleukin-6 and interleukin-8, have been found in two different studies to be potential biomarkers for incidence of dry AMD. Cytokines are signaling compounds in the cells that are involved in a variety of immunological, inflammatory, and infectious diseases. Janice C. Law, MD, and her [Read More]

A Summary of Risk Factors for AMD

by Wendy Strouse Watt, O.D. October 2003 (Updated November 2008) Research has revealed new risk factors in the development of age-related macular degeneration (AMD). Called epidemiological studies, they show correlations of the disease with obesity and consumption of certain dietary fats. These discoveries are being added to the list of more commonly-known risk factors, including [Read More]